UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2020 | 2020-05-04 | 0.00 | 0.00 |
| Q4 2019 | 2020-03-12 | -0.14 | -0.14 |
| Q3 2019 | 2019-11-04 | -0.17 | -0.17 |
| Q2 2019 | 2019-08-01 | -0.19 | -0.19 |
| Q1 2019 | 2019-05-02 | -0.19 | -0.19 |
| Q4 2018 | 2019-03-13 | 0.01 | 0.01 |
| Q3 2018 | 2018-11-01 | -0.26 | -0.26 |
| Q2 2018 | 2018-08-02 | -0.20 | -0.20 |
| Q1 2018 | 2018-05-03 | -0.08 | -0.08 |
| Q4 2017 | 2018-03-07 | -0.33 | -0.33 |
| 2016-02-10 | Downgrade | WallachBeth Capital | Hold to Sell | |
| 2016-02-10 | Downgrade | Piper Jaffray | Overweight to Neutral | $4.00 to $0.75 |
| 2016-02-10 | Downgrade | Ladenburg Thalmann | Buy to Neutral | |
| 2016-02-10 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | $4.00 to $0.75 |
| 2016-02-08 | Lower Price Target | Piper Jaffray | Overweight | $8.00 to $4.00 |
| 2016-02-08 | Lower Price Target | S&P Equity Research | $0.48 to $0.39 | |
| 2016-01-05 | Reiterated Rating | Piper Jaffray | Overweight | $8.00 |
| 2015-12-10 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-11-09 | Downgrade | WallachBeth Capital | Buy to Hold | $4.50 to $1.60 |
| 2015-09-23 | Reiterated Rating | Piper Jaffray | Buy | $8.00 |
| 2015-08-14 | Reiterated Rating | Roth Capital | Buy | $4.50 |
| 2015-06-01 | Set Price Target | Roth Capital | Buy | $4.50 |
| 2015-06-01 | Reiterated Rating | Janney Montgomery Scott | Buy to Fair Value | $3.50 to $1.94 |
| 2015-05-10 | Reiterated Rating | HC Wainwright | Buy | $6.00 to $4.00 |
| 2015-03-23 | Set Price Target | Roth Capital | Buy | $4.50 |
| 2015-03-09 | Set Price Target | Piper Jaffray | $6.00 to $8.00 | |
| 2014-09-08 | Initiated Coverage | Piper Jaffray | Overweight | $6.00 |
| 2014-08-05 | Upgrade | WallachBeth | Hold to Buy | $4.50 |
| 2014-08-05 | Upgrade | WallachBeth Capital | Hold to Buy | $4.50 |
| 2014-05-22 | Initiated Coverage | Ladenburg Thalmann | Buy | $6.00 |
| 2014-03-19 | Initiated | WallachBeth | Hold | $4.50 |
| 2014-03-19 | Initiated Coverage | WallachBeth Capital | Hold | $4.50 |
| 2013-11-04 | Initiated Coverage | HC Wainwright | Buy | $4.00 |
| 2013-10-29 | Initiated Coverage | Janney Montgomery Scott | Buy | |
| 2013-10-07 | Reiterated Rating | Wells Fargo & Co. | Positive | |
| 2013-10-07 | Reiterated Rating | Wells Fargo | Positive |
| 2016-02-10 | Downgrade | WallachBeth Capital | Hold to Sell | |
| 2016-02-10 | Downgrade | Piper Jaffray | Overweight to Neutral | $4.00 to $0.75 |
| 2016-02-10 | Downgrade | Ladenburg Thalmann | Buy to Neutral | |
| 2016-02-10 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | $4.00 to $0.75 |
| 2016-02-08 | Lower Price Target | Piper Jaffray | Overweight | $8.00 to $4.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CTIC 46 funds of 2183 total. Show all
| Fund name | Ticker shares |
|---|---|
| ORBIMED ADVISORS LLC | 9.52M |
| NEA Management Company, LLC | 7.14M |
| BVF INC/IL | 6.93M |
| Stonepine Capital Management, LLC | 4.07M |
| BlackRock Institutional Trust Company, N.A. | 3.46M |
| Vanguard Group, Inc | 2.15M |
| RENAISSANCE TECHNOLOGIES LLC | 2.10M |
| BlackRock Inc. | 0.93M |
| CAXTON CORP | 0.62M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.42M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.11M |
| NORTHERN TRUST CORP | 97371 |
| TEACHERS ADVISORS INC | 96473 |
| TWO SIGMA ADVISERS, LLC | 91883 |
| BlackRock Fund Advisors | 52768 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ORBIMED ADVISORS LLC | 3.33% (5000000) | AGLE / AMBI / ANTH / ATHX / BOLD / BONE / CRVS / CTIC / ICPT / KALA / LOXO / MRTX / OTIC / RLYP / ROKA / SIEN / SUPN / SYBX / XLRN / |
| BIANCO JAMES A President and CEO | 1.19% (1780133) | CTIC / |
| BVF PARTNERS L P/IL | 0.86% (1295582) | ARQL / ARRY / CAPS / CCXI / CNCE / CTIC / INFI / LGND / NBIX / ONTY / PTN / RGDO / RGEN / RIGL / TRGT / XENE / |
| SINGER JACK W EVP, Global Medical Affairs | 0.66% (994057) | CTIC / |
| BIANCO LOUIS A EVP, Finance & Administration | 0.42% (622933) | CTIC / |
| BAUER JOHN H | 0.40% (599011) | CTIC / |
| Plunkett Matthew EVP, Corporate Development | 0.35% (526210) | CTIC / |
| GREGORIAN VARTAN | 0.31% (468937) | CTIC / |
| BENNER STEVEN E EVP, Chief Medical Officer | 0.24% (363371) | CTIC / |
| MUNDINGER MARY ONEIL | 0.24% (360019) | CTIC / |
| SEELEY BRUCE J. EVP, Chief Commercial Officer | 0.21% (310000) | CTIC / NSTG / |
| Tuckson Reed Vaughn | 0.06% (92424) | CTIC / LPNT / |
| Telling Fred | 0.05% (78874) | CTIC / OGEN / |
| LOVE RICHARD L | 0.05% (73718) | CTIC / PRXL / |
| NUDELMAN PHILLIP M PHD | 0.05% (73129) | CTIC / |
| Ignagni Karen | 0.04% (66192) | CTIC / |
| PERRY MATTHEW D See Explanation of Responses | 0.03% (43139) | CTIC / XOMA / |
| Metzger Michael A | 0.01% (20121) | CTIC / RGDO / RGDX / |
Undercovermarket.com